(-) Cellect Biotechnology ( APOP ), which was sinking by more than 47% after the company priced an underwritten public offering of 1.889 million units at $1.50 each and 2.445 million pre-funded units at $1.49 apiece for total proceeds of about $6.5 million.
(-) Microbot Medical ( MBOT ) was down over 12% as it filed a preliminary prospectus for a public offering of up to 996,016 common shares and up to the same number of pre-funded warrants to purchase common shares.
(-) Seattle Genetics Inc. ( SGEN ) was more than 9% lower as it said adjusted loss per share in the fourth quarter sank to $0.75 from a loss of $0.41 in the year-ago quarter, missing analysts’ estimates for a loss of ($0.43) compiled by Capital IQ.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.